341 results on '"Peterson, Yuri"'
Search Results
2. Inhibition of complement C3 prevents osteoarthritis progression in guinea pigs by blocking STAT1 activation
3. First analytical confirmation of drug-induced crystal nephropathy in felines caused by GS-441524, the active metabolite of Remdesivir
4. Opportunistic pathogen Porphyromonas gingivalis targets the LC3B-ceramide complex and mediates lethal mitophagy resistance in oral tumors
5. A human iPSC-derived hepatocyte screen identifies compounds that inhibit production of Apolipoprotein B
6. PharML.Bind: Pharmacologic Machine Learning for Protein-Ligand Interactions
7. The Convergence of HPC, AI and Big Data in Rapid-Response to the COVID-19 Pandemic
8. Synthesis and evaluation of small molecule inhibitors of LSD1 for use against MYCN-expressing neuroblastoma
9. The Convergence of HPC, AI and Big Data in Rapid-Response to the COVID-19 Pandemic
10. The conformational signature of β-arrestin2 predicts its trafficking and signalling functions
11. Development of a Novel Humanized Monoclonal Antibody to Secreted Frizzled-Related Protein-2 That Inhibits Triple-Negative Breast Cancer and Angiosarcoma Growth In Vivo
12. Icmt (Isoprenylcysteine Carboxyl Methyltransferase)
13. Docking optimization, variance and promiscuity for large-scale drug-like chemical space using high performance computing architectures
14. Supplementary Methods and Materials from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
15. Table S1 from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
16. Data from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
17. Figure S1 from Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib
18. Stimulation of Natural Killer Cells with Small Molecule Inhibitors of CD38 for the Treatment of Neuroblastoma
19. Author Correction: Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol
20. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis
21. Frizzled-5: a high affinity receptor for secreted frizzled-related protein-2 activation of nuclear factor of activated T-cells c3 signaling to promote angiogenesis
22. Identification and Characterization of Novel Small-Molecule SMOX Inhibitors
23. Development of inhibitors of heterotrimeric Gαi subunits
24. The conformational signature of [beta]-arrestin2 predicts its trafficking and signalling functions
25. Application of Pharmacokinetic Prediction Platforms in the Design of Optimized Anti-Cancer Drugs
26. Small molecules targeting the NADH-binding pocket of VDAC modulate mitochondrial metabolism in hepatocarcinoma cells
27. 434 In silico ADMET optimization and preliminary biologic activity of novel spermine oxidase inhibitors as neuroprotective agents
28. 432 - Inhibition of Complement Component 3 to Treat Primary Osteoarthritis
29. Stimulation of natural killer cells with small molecule inhibitors of CD38 for the treatment of neuroblastoma.
30. The Chemical Relationship Among Beta-Lactam Antibiotics and Potential Impacts on Reactivity and Decomposition
31. Extracorporeal Removal of Thermosensitive Liposomal Doxorubicin from Systemic Circulation after Tumor Delivery to Reduce Toxicities
32. Icmt (Isoprenylcysteine Carboxyl Methyltransferase)
33. Structural and pharmacological basis for the induction of mitochondrial biogenesis by formoterol but not clenbuterol
34. Identification of selected therapeutic agents as inhibitors of carboxylesterase 1: Potential sources of metabolic drug interactions
35. Neuropilin-2b facilitates resistance to tyrosine kinase inhibitors in non–small cell lung cancer
36. Newly Identified Chemicals Preserve Mitochondrial Capacity and Decelerate Loss of Photoreceptor Cells in Murine Retinal Degeneration Models
37. Design, synthesis, and biological evaluation of CD38 inhibitors for the treatment of cancer
38. Prediction and In Vitro Evaluation of Selected Protease Inhibitor Antiviral Drugs as Inhibitors of Carboxylesterase 1: A Potential Source of Drug-Drug Interactions
39. Selective targeting of CD38 hydrolase and cyclase activity as an approach to immunostimulation
40. High-throughput respirometric assay identifies predictive toxicophore of mitochondrial injury
41. Time-dependent inhibition of isoprenylcysteine carboxyl methytransferase by indole-based small molecules
42. Biasing the Parathyroid Hormone Receptor
43. Hydrophilic anilinogeranyl diphosphate prenyl analogues are RAS function inhibitors
44. Deep Learning Predicts Protein-Ligand Interactions
45. Inap
46. Interferon-Inducible RNA-Dependent Protein Kinase
47. Integrin α1 (ITGA1)
48. Interferon-Inducible eIF2α Kinase
49. Icmt (Isoprenylcysteine Carboxyl Methyltransferase)
50. IL-1 Inducible Nuclear Ankyrin-Repeat Protein (INAP)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.